U.S. regulators this week gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.

U.S. President Donald Trump, Eli Lilly (LLY.N) and Novo Nordisk (NOVOb.CO) signed a deal in November to slash the prices of ...

Some Medicare enrollees may soon be able to access super-popular drugs for obesity under a voluntary model program, the Centers for Medicare and Medicaid Services announced Tuesday. Eligible ...

Regulators at the U.S. Food and Drug Administration on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.

The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo Nordisk ...

Hidden beneath a laboratory floor is a machine capable of applying one million pounds of precisely measured force. It exists so engineers can calibrate sensors used to test rockets, aircraft, and ...

The US Food and Drug Administration today approved a pill version of the blockbuster anti-obesity drug Wegovy. Made by Novo ...

The FTC warns that promises like fast weight loss or “magic” solutions are signs of scams. Speak to a healthcare provider before starting a new weight loss treatment.

A registered dietitian (R.D.) can be a big source of help in guiding you to eat healthier for overall well-being, gaining ...

The U.S. government is finally flexing its negotiating muscle to reduce GLP-1 prices and expand access to these medicines — for weight loss — in federal health programs. President Trump’s ...

President Donald Trump hailed his deal to slash the price of blockbuster weight loss drugs as a game changer, promising to make Wegovy and Zepbound more affordable for millions of Americans. But major ...